Sera Medicines
Biotechnology Research • • 11-20 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Company Formation, Fundraising, Protein Engineering, Antibody Discovery, Bd&L, Biologics R&D |
| Founded | 2023 |
| Employees | 11-20 |
Key Contacts at Sera Medicines
Luis Zuniga
Senior Director - Preclinical Biology
Adrienne Rothschilds
Senior Director, Discovery And Translation
William Bonificio
Co-Founder And Chief Business Officer
Muhammad Khuram Choudhry
Associate Director, Finance
Sera Medicines Email Formats
Sera Medicines uses 1 email format. The most common is {first name} (e.g., john@seramedicines.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@seramedicines.com | 100% |
About Sera Medicines
Sera Medicines is a biologics-focused accelerator advancing next-generation protein therapeutics with the potential to be transformative for patients. Our team consists of experts in biology, chemistry, antibody engineering, drug discovery, manufacturing, clinical development, and other critical functions to create and launch exceptional companies around next-generation therapies. Once a program incubated at Sera achieves key value inflection, we enable rapid progression toward and beyond the clinic via the formation and financing of spinouts, such as Tenet Medicines and Navigator Medicines.
Sera Medicines revenue & valuation
| Annual revenue | $1,283,325 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Sera Medicines has 5 employees across 3 departments.
Departments
Number of employees
Funding Data
Sera Medicines has never raised funding before.
Denmark
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
